Science Based Articles

Following are published, science-based articles regarding inflammatory breast cancer.

Click the title to read the full article.

• In Vivo Simvastatin and Brain Radiation in a Model of HER2⁺ Inflammatory Breast Cancer Brain Metastasis

• The Lymphatic System in Mammary Gland Biology and Cancer

• New Drug that works on all forms of Breast cancer

• Targeting Signaling Pathways in Inflammatory Breast Cancer
• Literature-Wide Association Studies (LWAS) for a Rare Disease: Drug Repurposing for Inflammatory Breast Cancer
• Decorin, a novel negative modulator of E-cadherin in inflammatory breast cancer
• Common cholesterol drugs could slow spread of breast cancer to brain
• FDA Approves New Therapy for Triple Negative Breast Cancer That Has Spread, Not Responded to Other Treatments
• Advancing Cancer Research and Medicine with Single-Cell Genomics
• For Metastatic HER2-Positive Breast Cancer, New Treatments Emerge
• A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer
• Fixed-Dose Pertuzumab Plus Trastuzumab Noninferior to IV Formulation in HER2-Positive Breast Cancer

• Identifying Deficiencies in Inflammatory Breast Cancer Care

• Genetic testing found a variant of uncertain significance.
• MARCKS as a Potential Targeted Therapy in Inflammatory Breast Cancer
• New Target Identified for Triple-Negative Breast Cancer Treatment
• Surgical lymphedema treatment: 8 things to know
• 6/20/2023  Inflammatory Breast Cancer Treatment Algorithm

• International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

• The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer

• JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states

Most recent algorithm 06/20/2023:  An algorithm of care including post treatment treatment care.